Company: LENZ
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001628280-25-016813
Chunk: 17

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-04
Form: POS AM
Chunk 17
---
 shares of Common Stock set forth below, subject to community property laws where applicable.

We cannot advise you as to whether the selling securityholders will in fact sell any or all of such Common Stock. In addition, the selling securityholders may sell, transfer or otherwise dispose of, at any time and from time to time, the Common Stock in transactions exempt from the registration requirements of the Securities Act after the date of this prospectus. Information about the selling securityholders, including those listed below, may change over time. Since the effectiveness of the initial prospectus, certain securityholders may have sold or otherwise transferred their securities registered thereunder. For purposes of this table, we have assumed that the selling securityholders will have sold all of the shares of Common Stock covered by this prospectus upon the completion of the offering.

Selling securityholder information for each additional selling securityholder, if any, will be set forth by a prospectus supplement to the extent required prior to the time of any offer or sale of such selling securityholder’s shares pursuant to this prospectus. Any prospectus supplement may add, update, substitute, or change the information contained in this prospectus, including the identity of each selling securityholder and the number of shares registered on its behalf. A selling securityholder may sell or otherwise transfer all, some or none of such shares in this offering. See “ Plan of Distribution .”

| Name of Selling Securityholder      |     | Common       
 Stock        
 Beneficially 
 Owned        
 Prior to     
 Offering     |           |     |        |     | Number of 
 Shares of 
 Common    
 Stock     
 Being     
 Offered   |           |     |         |     | Common Stock    
 Beneficially    
 Owned After the 
 Offered Shares  
 of              
 Common Stock    
 are Sold        |         |     |     |   |
|                                     |     |              |           |     | Number |     |           |           |     | Percent |     |                 |         |     |     |   |
| RTW Biotech Opportunities, Ltd.(1)  |     |              |   108,351 |     |        |     |           |    15,387 |     |         |     |                 |  92,964 |     |     | * |
| RTW Innovation Master Fund, Ltd.(1) |     |              |   316,880 |     |        |     |           |   103,902 |     |         |     |                 | 212,978 |